Workflow
Elysee Redeems $1,685,000 of Convertible Debentures
TMX Newsfile· 2025-12-17 12:00
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Elysee Development Corp. (TSXV: ELC) (FSE: QLDN) (the "Company") announces that it provided notice to the holders of its 8% unsecured convertible debentures (the "Debentures") that it would prepay its obligations under the Debentures on December 16, 2025. As such, the Company has proceeded with such prepayment and paid an aggregate of $2,106,250 plus accrued interest to such holders, settling Debentures with an aggregate principal amount o ...
Alset AI Announces Non-Brokered Private Placement Offering of up to $700,000
Accessnewswire· 2025-12-17 12:00
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR PUBLICATION, RELEASE OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESS Newswire / December 17, 2025 / Alset AI Ventures Inc. (TSXV:GPUS)(OTC PINK:GPUSF)(FSE:1R60)(WKN:A40M0J) ("Alset AI" or the "Company"),an artificial intelligence ("AI") venture company advancing innovation through strategic investment and cloud computing solutions, is pleased to announce a non-brokere ...
Sagimet Biosciences and TAPI Announce Global License Agreement for Innovative Forms of Resmetirom API for Sagimet’s Fixed Dose Combination Program
Globenewswire· 2025-12-17 12:00
License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applicationsCollaboration supports Sagimet’s fixed-dose combination (FDC) program currently in clinical developmentSagimet’s Phase 1 pharmacokinetic (PK) trial of combination of denifanstat and resmetirom is underway with topline data anticipated by the end of 2025Sagimet anticipates selecting one of the innovative forms of resmeti ...
Cathedra Bitcoin Inc. Issues Shareholder Letter and Operational Update
TMX Newsfile· 2025-12-17 12:00
CEO Letter to ShareholdersToronto, Ontario--(Newsfile Corp. - December 17, 2025) - Cathedra Bitcoin Inc. (TSXV: CBIT) (OTCQB: CBTTF) ("Cathedra", the "Company", "we" or "our") today released the following letter to shareholders from Chief Executive Officer Joel Block, outlining the Company's strategic progress, operational milestones, and outlook for 2026.Building the Foundation for Long-Term ValueA Letter from the Chief Executive OfficerTo Our Shareholders,As we close 2025, I want to reflect on the progre ...
Xali Gold to Close First Tranche of Private Placement December 19, 2025
Globenewswire· 2025-12-17 12:00
Not for dissemination in the United States or for distribution to U.S. Newswire Services VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that it plans to close the first tranche of the previously announced non–brokered private placement (the “Private Placement”) on December 19th, 2025, raising approximately C$1 Million. A second tranche of approximately C$0.5 Million is planned to close on or about Tuesday, Decem ...
Greenfire Resources Announces Preliminary Results for Rights Offering
TMX Newsfile· 2025-12-17 12:00
Calgary, Alberta--(Newsfile Corp. - December 17, 2025) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company") today announced preliminary results of its C$300 million rights offering, which expired at 4:00 p.m. (Calgary time) on December 16, 2025 (the "expiration date"). Upon closing of the rights offering, the Company expects to issue 55,147,058 common shares, representing the maximum number of common shares available under the rights offering, without reliance on the standby com ...
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million
Prnewswire· 2025-12-17 12:00
HOLON, Israel, Dec. 17, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical- stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that it has agreed with AstraZeneca to monetize a portion of Compugen's rilvegostomig future royalties. Compugen has amended the exclusive license agreement with AstraZeneca, previously entered into in March 2018, to strengthen Compugen's balance sheet and advance its innovative and d ...
TTEC Digital Named a Leader and Star Performer in Everest Group’s 2025 PEAK Matrix® for Mid-market Digital Transformation Services
Globenewswire· 2025-12-17 12:00
AUSTIN, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- TTEC Holdings Inc. (NASDAQ: TTEC), a leading global CX (customer experience) technology and services innovator for AI-enabled CX, today announced that TTEC Digital has been recognized as a Leader and Star Performer in the 2025 Everest Group PEAK Matrix® Assessment for Digital Transformation Services for Mid-market Enterprises. Everest Group’s PEAK Matrix® is a renowned industry benchmark that measures impact in market adoption, portfolio mix, value, vision, ...
Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
Globenewswire· 2025-12-17 12:00
FRIENDSWOOD, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the largest prospective, multicenter study to date comparing next-generation sequencing (NGS)-based gene mutation analysis with the combination of DecisionDx-UM and Preferentially Expressed Antigen in Melanoma (PRAME) gene expression for predicting outcomes in patients with uveal melanoma (UM). The study, tit ...
West Point Gold Expands Northeast Tyro to Depth and to the North, Drilling 24.4 m of 5.92 g/t Au from 120.4 m and 16.8 m of 8.3 g/t from 158.5 m
TMX Newsfile· 2025-12-17 12:00
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - West Point Gold Corp. (TSXV: WPG) (OTCQB: WPGCF) (FSE: LRA0) ("West Point Gold" or the "Company") is pleased to announce the results for three holes from the high-grade zone at Northeast (NE) Tyro, part of the ongoing 15,000 metre (m) drill program at its flagship Gold Chain Project in Arizona. The Company is reporting assay results for three drill holes (658m), GC25-82 through GC25-84. Highlights:Hole GC25-84 returned 24.4 m of 5.92 g/t A ...